Abbott Laboratories (ABT)
129.46
-0.38 (-0.29%)
At close: Apr 24, 2025, 3:59 PM
129.70
0.19%
After-hours: Apr 24, 2025, 08:00 PM EDT
Abbott Laboratories Revenue Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostic Products Revenue | n/a | 5.3B | 4.8B | 4.5B | n/a | 4.2B | 4.2B | 4.1B | 3.5B | 3.9B | 3.9B | 5.29B | 3.82B | 3.91B | 3.9B | 4.01B | 305M | 3.6B | 3.5B | 3.4B | n/a | 3.2B | 3.1B | 3B | n/a | 2.8B | 2.8B | 2.9B | 1.91B | 1.28B | 1.27B | 1.16B | 1.26B | 1.21B | 1.23B | 1.12B | 1.22B | 1.16B | 1.18B | 1.09B | 1.24B | 1.18B | 1.19B | 1.12B | 1.2B | 1.13B | 1.14B | 1.09B | 1.13B | 1.04B | 1.08B | 1.04B | 3.1B | 1.02B |
| Diagnostic Products Revenue Growth | -100.00% | +10.42% | +6.67% | n/a | -100.00% | 0.00% | +2.44% | +17.21% | -10.31% | 0.00% | -26.22% | +38.45% | -2.40% | +0.31% | -2.84% | +1216.07% | -91.53% | +2.86% | +2.94% | n/a | -100.00% | +3.23% | +3.33% | n/a | -100.00% | 0.00% | -3.45% | +52.15% | +49.02% | +0.47% | +9.93% | -7.80% | +3.54% | -1.06% | +9.66% | -8.36% | +5.54% | -1.78% | +7.69% | -11.50% | +4.66% | -0.76% | +6.45% | -6.68% | +6.40% | -0.88% | +4.32% | -3.72% | +8.45% | -3.34% | +3.45% | -66.40% | +202.54% | n/a |
| Established Pharmaceutical Products Revenue | 1.27B | 1.41B | 1.29B | 1.23B | 1.22B | 1.37B | 1.29B | 1.19B | 2.44B | 1.33B | 436M | 1.15B | 1.2B | 1.26B | 1.18B | 1.07B | 1.15B | 1.1B | 1.01B | 1.04B | 1.17B | 1.21B | 1.11B | 992M | 1.09B | 1.16B | 1.13B | 1.04B | 1.15B | 1.17B | 1.02B | 950M | 979M | 1.01B | 980M | 888M | 885M | 961M | 977M | 897M | 922M | 771M | 1.22B | 1.15B | 1.29B | 1.24B | 1.22B | 1.23B | 6.49B | 5.69B | 5.63B | 5.33B | 16.75B | 5.69B |
| Established Pharmaceutical Products Revenue Growth | -9.82% | +8.66% | +5.55% | +0.33% | -10.67% | +6.29% | +8.24% | -51.25% | +83.94% | +204.13% | -61.99% | -4.66% | -4.90% | +7.20% | +10.28% | -6.71% | +4.37% | +8.49% | -2.97% | -11.07% | -3.14% | +9.39% | +11.69% | -8.99% | -5.95% | +2.66% | +8.14% | -8.82% | -2.22% | +14.69% | +7.47% | -2.96% | -3.26% | +3.27% | +10.36% | +0.34% | -7.91% | -1.64% | +8.92% | -2.71% | +19.58% | -36.60% | +5.65% | -10.64% | +4.29% | +1.40% | -1.22% | -81.00% | +14.02% | +1.14% | +5.57% | -68.18% | +194.50% | n/a |
| Medical Devices Revenue | 5.05B | 4.75B | 4.73B | 4.45B | 4.44B | 4.25B | 4.29B | 3.9B | 7.07B | 3.62B | n/a | 3.56B | 3.75B | 3.63B | 3.67B | 3.32B | 5.79B | 3.17B | 2.42B | 400M | 1.87B | 1.87B | 1.88B | 1.79B | 1.78B | 1.84B | 1.86B | 1.76B | 1.78B | 1.77B | 1.73B | 1.64B | 1.73B | 1.75B | 1.74B | 1.67B | 1.8B | 1.79B | 1.72B | 1.67B | 1.8B | 1.79B | 1.73B | 1.63B | 1.7B | 1.64B | 1.7B | 1.7B | 1.72B | 1.6B | 1.58B | 1.57B | 4.47B | 1.54B |
| Medical Devices Revenue Growth | +6.43% | +0.27% | +6.31% | +0.23% | +4.57% | -1.07% | +10.13% | -44.85% | +95.60% | n/a | n/a | -4.91% | +3.22% | -0.93% | +10.42% | -42.70% | +82.78% | +30.83% | +505.75% | -78.59% | -0.32% | -0.05% | +4.63% | +0.84% | -3.32% | -1.08% | +5.81% | -1.57% | +0.90% | +2.14% | +5.42% | -5.25% | -1.25% | +0.86% | +4.13% | -7.17% | +0.61% | +4.19% | +2.88% | -7.48% | +0.95% | +3.24% | +6.13% | -4.17% | +4.10% | -4.05% | +0.29% | -0.99% | +6.92% | +1.33% | +1.15% | -64.96% | +190.76% | n/a |
| Nutritional Products Revenue | 2.13B | 2.07B | 2.15B | 2.07B | 2.04B | 2.07B | 2.08B | 1.97B | 3.77B | 1.79B | n/a | 1.89B | 2.04B | 2.11B | 2.11B | 2.04B | 1.94B | 1.92B | 1.88B | 1.9B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Nutritional Products Revenue Growth | +3.05% | -3.91% | +3.97% | +1.47% | -1.69% | -0.14% | +5.54% | -47.82% | +110.03% | n/a | n/a | -7.25% | -3.13% | 0.00% | +3.54% | +5.17% | +0.62% | +2.18% | -1.10% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 14.85B | 14.08B | 14.84B | 15.52B | 12.58B | 3.41B | 3.32B | 1.07B | 1.74B | 1.76B | 8.75B |
| Non-Us Revenue Growth | +5.41% | -5.10% | -4.34% | +23.33% | +268.48% | +2.96% | +209.91% | -38.51% | -1.08% | -79.90% | n/a |
| C [H] Revenue | 2.11B | 2.25B | 2.13B | 2.57B | n/a | 1.75B | 1.62B | 922M | 933M | 2.34B | 1.85B |
| C [H] Revenue Growth | -6.21% | +5.63% | -17.07% | n/a | n/a | +8.15% | +75.60% | -1.18% | -60.16% | +26.87% | n/a |
| Germany Revenue | 2.54B | 2.35B | 2.34B | 1.7B | n/a | 1.4B | 1.33B | 1.44B | 2.44B | 2.11B | 2.02B |
| Germany Revenue Growth | +8.27% | +0.21% | +38.05% | n/a | n/a | +4.80% | -7.56% | -40.93% | +15.80% | +4.10% | n/a |
| India Revenue | 1.82B | 1.75B | 1.65B | n/a | n/a | 1.44B | 1.33B | 960M | 1.88B | 11.01B | 2B |
| India Revenue Growth | +3.83% | +6.12% | n/a | n/a | n/a | +8.22% | +38.12% | -49.02% | -82.90% | +450.22% | n/a |
| Japan Revenue | 1.44B | 1.51B | 1.93B | n/a | n/a | 975M | 930M | 5.28B | 10.55B | 16.01B | 15.19B |
| Japan Revenue Growth | -4.76% | -21.69% | n/a | n/a | n/a | +4.84% | -82.40% | -49.95% | -34.09% | +5.40% | n/a |
| Netherlands Revenue | 1.12B | 1.07B | 1.34B | n/a | n/a | 11.53B | 11.21B | 792M | 16.78B | n/a | n/a |
| Netherlands Revenue Growth | +4.66% | -19.61% | n/a | n/a | n/a | +2.84% | +1316.04% | -95.28% | n/a | n/a | n/a |
| Switzerland Revenue | 1.75B | 1.64B | 18.14B | n/a | n/a | n/a | n/a | 6.27B | n/a | n/a | n/a |
| Switzerland Revenue Growth | +6.65% | -90.97% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 16.32B | 15.45B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +5.64% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.9B | 2.92B | 2.94B | 2.7B | 2.6B | 2.62B | 2.62B | 2.97B | 2.73B | 2.76B | 2.79B | 3.05B | 2.77B | 2.73B | 2.78B | 2.57B | 2.3B | 2.28B | 2.55B | 2.41B | 2.44B | 2.43B | 2.48B | 2.36B | 2.38B | 2.47B | 2.54B | 2.46B | 2.1B | 2.13B | 2.42B | 1.61B | 1.63B | 1.74B | 1.7B | 1.66B | 1.67B | 1.73B | 1.74B |
| Selling, General, and Administrative Revenue Growth | -0.69% | -0.95% | +8.84% | +3.96% | -0.69% | +0.15% | -12.04% | +8.86% | -0.94% | -1.08% | -8.56% | +10.16% | +1.50% | -2.05% | +8.29% | +11.64% | +1.14% | -10.68% | +5.59% | -1.11% | +0.25% | -1.78% | +5.04% | -0.76% | -3.61% | -2.99% | +3.25% | +17.29% | -1.55% | -12.05% | +50.65% | -1.17% | -6.28% | +2.30% | +2.60% | -0.66% | -3.53% | -0.58% | n/a |
| Research and Development Revenue | 713M | 698M | 679M | 690M | 672M | 715M | 654M | 725M | 782M | 684M | 697M | 762M | 672M | 654M | 654M | 698M | 580M | 564M | 578M | 595M | 596M | 577M | 672M | 562M | 574M | 575M | 589M | 613M | 562M | 513M | 547M | 343M | 352M | 348M | 379M | 369M | 378M | 345M | 313M |
| Research and Development Revenue Growth | +2.15% | +2.80% | -1.59% | +2.68% | -6.01% | +9.33% | -9.79% | -7.29% | +14.33% | -1.87% | -8.53% | +13.39% | +2.75% | 0.00% | -6.30% | +20.34% | +2.84% | -2.42% | -2.86% | -0.17% | +3.29% | -14.14% | +19.57% | -2.09% | -0.17% | -2.38% | -3.92% | +9.07% | +9.55% | -6.22% | +59.48% | -2.56% | +1.15% | -8.18% | +2.71% | -2.38% | +9.57% | +10.22% | n/a |